On 26 September 2025, the Indian stock market experienced a notable downturn with the BSE Sensex closing 0.68% lower at 81,159.68 and the NSE Nifty 50 down 0.66%, ending at 24,890.85 amid negative investor sentiment.
Retail investor sentiment was cautious and subdued, affected by ongoing uncertainty and a continuation of foreign institutional investors (FIIs) net selling for a fourth consecutive session, although domestic institutional investors (DIIs) provided support through buying.
Market volatility was high as investors reacted to global economic uncertainties and domestic factors, with selling pressure seen especially in the pharmaceutical and IT sectors.
The Indian rupee remained under pressure, nearing record lows against the US dollar at around 88.79, reflecting external vulnerabilities that weighed on overall market confidence.
Overall, the market environment was characterized by risk aversion and confusion, influenced by geopolitical and tariff-related developments impacting key sectors, leading to a cautious trading day.
Key Indices
NIFTY 50
24,655
-0.95%
SENSEX
80,426.46
-0.82%
Momentum Snapshot
Index
Price
1D
1M
1Y
Sensex
80,426.46
-0.82%
0.43%
-6.01%
Nifty 50
24,655
-0.95%
-0.23%
-5.96%
Nifty Next 50
67,145
-1.68%
0.52%
-12.90%
Nifty Midcap 100
56,379
-2.05%
-0.68%
-6.76%
Nifty Smallcap 250
16,683
-2.14%
-0.36%
-9.50%
Sector Highlights
FMCG
-0.47%
The FMCG sector declined 0.47% amid broad market weakness, with no specific positive triggers reported. The sector's downturn aligns with the overall market selloff driven by global and macroeconomic uncertainties.
Realty
-1.00%
The Realty sector fell 1.00%, pressured by persistent market weakness and cautious sentiment on demand amid rising interest rates and inflation concerns, with no discrete sector-specific news reported.
Auto
-1.02%
Auto sector declined 1.02%, influenced by continued selling pressure due to tariff concerns on heavy-duty trucks by the US (25% tariff announced), dampening export outlook and cost structures for manufacturers.
Pharma
-2.14%
Pharma sector declined sharply by 2.14% triggered by President Trump's announcement of a 100% tariff on branded or patented pharmaceutical products effective October 1, 2025, unless companies have begun building manufacturing plants in the US. This escalates fears of reduced exports and margin pressure.
IT
-2.45%
IT sector was down 2.45% due to renewed concerns over US trade policies impacting Indian exporters, including tariff risks and geopolitical uncertainties, resulting in broad foreign investment outflows and pessimism in the sector.
Sector Scoreboard
Sector
1D
1W
1Y
3Y
FMCG
-0.47%
-2.50%
-15.89%
+22.86%
Realty
-1.00%
-4.63%
-22.50%
+100.55%
Auto
-1.02%
-2.09%
-0.48%
+104.36%
Pharma
-2.14%
-2.64%
-5.47%
+74.28%
IT
-2.45%
-5.99%
-17.67%
+29.92%
Movers of the Day
Top Nifty Gainers
Larsen
2.34%
Larsen rose due to its strong performance outlook in infrastructure demand, bolstered by aggressive government spending in the sector.
Tata Motors
1.29%
Tata Motors gained as JLR resumed operations post-cyberattack, easing concerns over production disruptions.
ITC
1.25%
ITC rose on stable demand and optimistic outlook in FMCG amid festive consumption trends.
Eicher Motors
0.87%
Eicher Motors saw gains linked to high demand for premium motorcycles during the festival season.
Reliance
0.38%
Reliance rose slightly on steady core energy operations, despite broader market volatility.
Top Nifty Losers
M&M
-3.78%
M&M fell due to broader market sell-offs in auto and rural challenges impacting revenue expectations.
IndusInd Bank
-3.78%
IndusInd Bank saw declines caused by rupee weakness and increased forex risk, affecting banking sector confidence.
Eternal
-3.39%
Eternal dropped due to weaker overall market sentiment, particularly impacting small-cap and mid-cap stocks.
Tata Steel
-2.89%
Tata Steel declined amid heightened global trade uncertainties, including tariffs on key commodities.
Bajaj Finance
-2.73%
Bajaj Finance fell on concerns linked to rising cost of capital and potential challenges in unsecured loan growth.
Stock Spotlight Of The Day
Sun Pharma
Market Cap
3,80,526 Cr
Current Price
₹1,587
Stock P/E
76.4
Dividend Yield
1.01%
ROCE
16.8%
ROE
17.8%
Shareholding Changes (Impact Factors)
FIIs
QoQ
-0.7%
YoY
0.03%
Stable foreign holding
DIIs
QoQ
0.8%
YoY
0.21%
Stable domestic holding
Promoters
QoQ
0%
YoY
0%
No change in promoter holding
Quarterly Summary (Absolute)
Sales
QoQ
Severe drop
-22.04%
YoY
Strong momentum
24.54%
Expenses
QoQ
Reduced
-11.56%
YoY
Flat trend
-0.7%
Operating Profit
QoQ
Erosion
-36.73%
YoY
Huge margin gains
148.49%
Net Profit
QoQ
Collapsed
-62.3%
YoY
Profits soared
216.81%
Profit & Loss (Compounded)
Sales Growth
10 Years
11%
5 Years
13%
3 Years
14%
TTM
19%
Profit Growth
10 Years
17%
5 Years
7%
3 Years
73%
TTM
79%
Stock Price CAGR
10 Years
6%
5 Years
27%
3 Years
21%
1 Year
-16%
Return on Equity
10 Years
6%
5 Years
8%
3 Years
15%
Last Year
18%
Fundamental's Corner
The company displays robust fundamentals with accelerating sales growth, up from 11% over 10 years to 19% TTM, and an impressive profit CAGR of 79% TTM, though inconsistent over longer cycles. However, the stock's price CAGR has dipped (-16% over 1 year), indicating potential mismatch between improving financials and valuation re-rating.
Despite strong profitability (ROE at 17.8%) and stellar quarterly net profit growth (216.8% YoY), the elevated P/E of 76.4 suggests the stock may be overvalued for current earnings. Retail investors should monitor quarterly growth consistency while being cautious of high valuations.
News TidBits
Sun Pharma was impacted significantly after the US imposed 100% tariffs on Indian branded pharmaceutical exports, directly threatening its revenue streams.
The company's stock hit 52-week lows as concerns over supply chain disruptions and diminishing export competitiveness mounted in the pharma sector.
This development is expected to amplify pricing pressures on Sun Pharma, especially for its premium drug portfolio meant for international markets.
Analysts project prolonged earnings volatility for Sun Pharma, contingent on government trade policies and retaliatory measures to mitigate tariff effects.
Retail investors are advised to watch Sun Pharma closely for potential restructuring efforts or strategic pivots as global trade dynamics evolve.
Stacks on Stacks: Tip Time 🤑
The best investment decisions are made not during periods of euphoria but amidst clarity during market corrections, as sound opportunities often emerge in downturns.
Inside The Fund
Nippon India Large Cap Fund
Fund Size: ₹ 45012.18 Cr
NAV: ₹ 102.4742 (as on 25th September, 2025)
1 Year
0.42%
Category: -3.37%
2 Year
19.36%
Category: 16.56%
3 Year
20.80%
Category: 16.09%
5 Year
26.59%
Category: 20.08%
10 Year
15.83%
Category: 13.69%
Stocks Added
Stock
Sector
1M Change
Lupin Ltd.
Pharmaceuticals
0.99%
Stocks Removed
Stock
Sector
1M Change
HDFC Asset Management Co. Ltd.
Asset management company
-0.75%
Coal India Ltd.
Coal
-0.49%
Hindalco Industries Ltd.
Aluminium
-0.39%
Power Finance Corporation Ltd.
Financial institution
-0.35%
Top 10 Holdings
Stock
Holding %
1M Change
HDFC Bank Ltd.
8.26%
-0.67%
Reliance Industries Ltd.
6.19%
-0.12%
ICICI Bank Ltd.
5.12%
-0.41%
Axis Bank Ltd.
4.18%
0.19%
State Bank Of India
4.06%
-0.04%
Larsen & Toubro Ltd.
3.52%
-0.10%
ITC Limited
3.22%
-0.08%
Bajaj Finance Ltd.
3.03%
-0.07%
Hindustan Unilever Ltd.
2.98%
0.33%
GE T&D India Ltd.
2.87%
-0.09%
The Common Ground
Shows the commonly added & removed stocks by mutual funds last month
Top Added (4)
TVS Motor Company Ltd. - Preference Shares
5 funds
ICICI Prudential Multicap Fund - Direct Plan - Growth
0.01%
Axis Multicap Fund - Direct Plan - Growth
0.01%
HSBC Multi Cap Fund - Direct Plan - Growth
0.02%
Canara Robeco Multi Cap Fund - Direct Plan - Growth
0.02%
Invesco India Multicap Fund - Direct Plan - Growth
0.02%
Maruti Suzuki India Ltd.
2 funds
Nippon India Multicap Fund - Direct Plan - Growth
0.26%
Axis Multicap Fund - Direct Plan - Growth
0.53%
Cummins India Ltd.
2 funds
Axis Multicap Fund - Direct Plan - Growth
0.64%
HSBC Multi Cap Fund - Direct Plan - Growth
0.88%
Apollo Hospitals Enterprises Ltd.
2 funds
Axis Multicap Fund - Direct Plan - Growth
0.45%
Mahindra Manulife Multi Cap Fund - Direct Plan - Growth
1.08%
Top Removed (2)
Bharat Electronics Ltd.
2 funds
Quant Multi Cap Fund - Direct Plan - Growth
-0.09%
HSBC Multi Cap Fund - Direct Plan - Growth
-0.20%
Sonata Software Ltd.
2 funds
Canara Robeco Multi Cap Fund - Direct Plan - Growth
-0.25%
Invesco India Multicap Fund - Direct Plan - Growth
-0.65%
Top News Developments
US Tariff Blow to Indian Pharma Exports
The US announced a 100% tariff on Indian branded pharmaceutical exports, set to commence October 1, severely impacting India’s global market competitiveness.
Top pharma companies, including Sun Pharma and Cipla, face significant earnings risks, with stock prices already under pressure.
This development may lead to disruptions in pharma sector supply chains, prompting exploration of alternate export markets or price renegotiations.
FII Sell-Off Continues, Rupee Near Record Lows
FIIs pulled ₹5,098 crore out of Indian markets recently, marking heavy foreign outflows amid global geopolitical uncertainties.
The Indian rupee weakened to 88.79 per USD, increasing import costs and inflationary pressures, especially for sectors reliant on dollar-denominated inputs.
Banking, FMCG, and IT sectors are seeing mixed impacts, with asset pricing and earnings vulnerability intensifying due to forex risks.
Defence Stocks Under Pressure Amid Market Weakness
Defence stocks like Hindustan Aeronautics lost ground amidst concerns over lower government budget allocations for defence procurement.
Market-wide sell-offs fueled negative sentiment in heavy industries, undermining confidence in stocks tied to public spending like Tata Steel.
Investors are advised to monitor government policy responses closely, as global uncertainties continue to weigh on defence sector valuations.
FII / DII Snapshot
Yesterday
FII Net: ₹-4995.42 cr
DII Net: ₹5103.01 cr
August 2025
FII Net: ₹-46902.92 cr
DII Net: ₹94828.55 cr
Daily Flows
Date
FII Net
DII Net
25-Sep-2025
₹-4995.42 cr
₹5103.01 cr
24-Sep-2025
₹-2425.75 cr
₹1211.68 cr
23-Sep-2025
₹-3551.19 cr
₹2670.87 cr
22-Sep-2025
₹-2910.09 cr
₹2582.63 cr
19-Sep-2025
₹390.74 cr
₹2105.22 cr
Monthly Flows
Month
FII Net
DII Net
August 2025
₹-46902.92 cr
₹94828.55 cr
July 2025
₹-47666.68 cr
₹60939.16 cr
June 2025
₹7488.98 cr
₹72673.91 cr
May 2025
₹11773.25 cr
₹67642.34 cr
April 2025
₹2735.02 cr
₹28228.45 cr
March 2025
₹2014.18 cr
₹37585.68 cr
• Foreign Institutional Investors (FIIs) continued their consistent selling streak, netting outflows of ₹4,995.42 crore on September 25, marking one of the worst September outflows in recent years. This aligns with the broader trend of FIIs pulling significant funds from Indian equity markets amid global uncertainties, weakening Indian market sentiment. Meanwhile, Domestic Institutional Investors (DIIs) showed a contrasting pattern, net buying ₹5,103.01 crore, indicating localized confidence as they offset FIIs' sell-offs and provided some cushioning to market volatility.
IPO Watchlist
Ongoing IPOs
Pace Digitek's IPO, open till September 30, shows modest interest with a subscription rate of 0.17x and grey market premium of 14.61%, reflecting cautious sentiment.
TruAlt Bioenergy's IPO displays stronger demand with a subscription rate of 0.84x, supported by its growth potential in the renewable energy sector.
Jinkushal Industries demonstrates robust demand with a subscription rate of 5.04x, highlighting investor confidence in small-cap industrial companies.
Pace Digitek
819.15
Date: 26 Sept - 30 Sept
List: 6 Oct
Subscription: 0.17x
GMP: 14.61%
TruAlt Bioenergy
839.28
Date: 25 Sept - 29 Sept
List: 3 Oct
Subscription: 0.84x
GMP: 17.14%
Jinkushal Industries
116.15
Date: 25 Sept - 29 Sept
List: 3 Oct
Subscription: 5.04x
GMP: 17.36%
Epack Prefab Technologies T
504.00
Date: 24 Sept - 26 Sept
List: 1 Oct
Subscription: 3.13x
GMP: 0.98%
BMW Ventures T
231.66
Date: 24 Sept - 26 Sept
List: 1 Oct
Subscription: 1.5x
GMP: 4.04%
Upcoming IPOs
Advance Agrolife's IPO opens on September 30 with strong pre-listing anticipation due to its focus on agricultural innovation.
Om Freight Forwarders targets logistics sector opportunities with its IPO starting September 29, amidst rising interest in supply chain optimization.
Fabtech Technologies’ IPO, slated for September 29, attracts attention for its specialty solutions in healthcare manufacturing.
Advance Agrolife
192.86
Date:30 Sept - 3 Oct
List:8 Oct
Subscription: -
GMP: 10.00%
Om Freight Forwarders
122.31
Date:29 Sept - 3 Oct
List:8 Oct
Subscription: -
GMP: 8.15%
Fabtech Technologies
230.35
Date:29 Sept - 1 Oct
List:7 Oct
Subscription: -
GMP: 18.32%
Glottis
307.00
Date:29 Sept - 1 Oct
List:7 Oct
Subscription: -
GMP: 11.63%
Cha-Ching Cheatsheet 💵
Avoid anchoring biases when reviewing historical stock prices; focus instead on underlying fundamentals and the broader macroeconomic narrative.
The US President's announcement of a 100% tariff on pharmaceutical exports significantly impacted global markets, particularly pressuring the Indian pharma sector and dampening investor confidence worldwide.
Global equity markets showed mixed performance with European index futures rising sharply, while US S&P 500 futures remained flat, creating a cautious global trading backdrop.
Supply chain disruptions and inflation concerns persisted internationally, contributing to a risk-off mood among investors, affecting emerging markets including India.
Foreign portfolio investors' continuing net selling in India was partly driven by heightened global monetary uncertainties and the prospect of tightening in major economies.
Currency fluctuations, including a strengthening US dollar and depreciating emerging market currencies, influenced cross-border capital flows with direct effects on the Indian exchange rate and equity valuations.
Emerging Opportunities
Despite current headwinds, opportunities persist in the renewable energy sector, bolstered by recently announced supportive government policies aimed at scaling clean energy capacity and infrastructure.
The technology sector, especially companies focused on domestic digital infrastructure and AI-driven services, remains promising for medium- to long-term growth due to increasing digital adoption in India.
Financial services linked to rural and digital payments show potential growth driven by ongoing financial inclusion initiatives and advancements in fintech platforms.
Pharmaceuticals, though currently pressured, may present contrarian investment opportunities based on India's strong generic drug manufacturing base and evolving export markets beyond the US.
Infrastructure development tied to upcoming government-backed urban development and transport projects could offer growth avenues in construction materials, engineering, and related services sectors over the coming years.
Crypto Buzz
Name
Price
Market Cap
24h Change
ATH Change
Bitcoin (BTC)
$108766
$2.17T
-2.51%
-12.39%
Ethereum (ETH)
$3888.32
$469.10B
-2.89%
-21.46%
Tether (USDT)
$1.001
$173.54B
0.04%
-24.38%
XRP (XRP)
$2.71
$161.73B
-3.72%
-25.79%
BNB (BNB)
$934.92
$130.18B
-4.84%
-13.41%
Bitcoin dropped by 2.51% to $108,766, reflecting cautious sentiment in the crypto market due to global liquidity tightening and leveraged positions being unwound.
Ethereum fell 2.89% as broader market sentiment worsened, with declines seen across altcoins amidst heightened trading activity and rising liquidations.
BNB posted the steepest decline among major tokens at 4.84%, as regulatory concerns added bearish tone in the crypto ecosystem, prompting portfolio rebalancing.
Inside The Fund
